TRIUMPH/NCI F32 Postdoctoral Fellow
Ordered Chronologically
Posters
Targeting Polo-like Kinase 4 Triggers Polyploidy and Apoptotic Cell Death in TP53-Mutant Acute Myeloid Leukemia
63nd American Society of Hematology (ASH) 2020 (link)
This abstract received the ASH Abstract Achievement Award, which a merit-based award for trainees who are the first author and presenter on a high-scoring annual meeting abstract.
December 2021
MDS1-EVI1 Complex (MECOM) Activation Promotes Leukemic Stem Cell Quiescence By Upregulating CDKN1C/P57Kip2
62nd American Society of Hematology (ASH) 2020 (link)
This abstract received the ASH Abstract Achievement Award, which a merit-based award for trainees who are the first author and presenter on a high-scoring annual meeting abstract.
December 2020
EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
Gordon Research Conference - Cancer Genetics and Epigenetics (link)
The University of Rochester James Wilmot Cancer Institute 23rd Annual Scientific Symposium
April 2019
November 2018
ROLE OF THE ONCOGENE EVI1 IN LEUKEMIA-ASSOCIATED ANEMIA
The University of Rochester The Patricia Hinkle Symposium
The University of Rochester Research Poster Session
May 2018
February 2018
EVI1 EXPANDS MYELOPOIESIS VIA UPREGULATION OF SPI1 TRANSCRIPTION
The University of Rochester James Wilmot Cancer Institute 22nd Annual Scientific Symposium
November 2017
HIGH-LEVEL EVI1 REPROGRAMS HEMATOPOIETIC DIFFERENTIATION
European School of Hematology 4th International Conference on Acute Myeloid Leukemia
The 2017 University of Rochester Graduate Student Society (GSS) Poster Session
October 2017
May 2017
EVI1 EXPANDS MYELOPOIESIS VIA UPREGULATION OF SPI1 TRANSCRIPTION
The University of Rochester James Wilmot Cancer Institute 21st Annual Scientific Symposium
November 2016
Publications
Ordered Chronologically
3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features (link)
January 2023
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment (link)
September 2022
Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells (link)
August 2021
